Lumibird Medical® is announcing that
the HoloDoppler project led by its subsidiary Quantel Medical has been selected as part of the Health section of France 2030, financed by Bpifrance.
Lumibird Medical® Group renames its Polish subsidiary to Lumibird Medical® Polska, which moves to new offices in Warsaw to support its growth in the local market.
Lumibird Medical announces the launch of their two next generation Nd:YAG/SLT lasers, the Tango Neo and UltraQ Reflex Neo.
Lumibird Medical is proud to announce that it has received marketing approval in China for its Vitra 2 photocoagulation laser from the Chinese Health Authority (NMPA).
Lumibird Medical is proud to introduce its new website dedicated to eye care professionals, combining our complete range of products – Quantel Medical & Ellex brands.
Lumibird Medical® announces the launch of their next generation YAG/SLT laser, the Tango Reflex™ Neo, by Ellex®.
Lumibird Medical announces the opening of its new Indian subsidiary in Mumbai: Lumibird Medical India. This company aims to boost sales of Quantel Medical and Ellex products in India with a shared range of ultrasound platforms, ophthalmic lasers and equipment for the diagnosis and treatment of dry eye.
The value of Nd:YAG laser treatment for secondary cataract remains undisputed; and with the redesign of Quantel Medical’s flagship Nd:YAG Laser, Lumibird Medical delivers CapsuloTM; the next generation technology, continuing to support this important growing market need.
Lumibird Medical, leader in ophthalmic laser, today announces its new website: www.glaucoma-laser-assisted-solutions.com dedicated to laser therapies for each glaucoma stage.
Quantel Medical today announced the launch of C.STIMTM IPL system. Based on intense pulsed light technology, C.STIMTM is the new generation of IPL designed by Quantel Medical to treat dry eye disease. Dry eye is a huge public health problem affecting more than 700 million people in the word and it is the most common pathology in ophthalmic visits….